Atlas FDA

Cardiva VASCADE Family

FDA premarket approval P120016/S034 · decided 2024-01-03

Approval details

PMA number
P120016
Supplement
S034
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Cardiva VASCADE Family
Generic name
Device, hemostasis, vascular
Applicant
Cardiva Medical, Inc.
Date received
2023-12-05
Decision date
2024-01-03
Days to decision
29 days
Decision code
OK30
Product code
MGB
Advisory committee
Cardiovascular
Expedited review
No
Location
Santa Clara, CA
Statement
an additional controlled environment room at the approved Guaymas facility (Sonora, Mexico) for the Cardiva Vascade Family

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
CATALYST II AND III (K130124)Cardiva Medical, Inc.2013-03-14
CARDIVA CATALYST III SYSTEM WITH PROTAMINE SULFATE (K082930)Cardiva Medical, Inc.2009-02-13
BOOMERANG CATALYST/BOOMERANG CATALYST II SYSTEM (K072297)Cardiva Medical, Inc.2007-09-12
BOOMERANG WIRE /BOOMERANG PLUS WIRE SYSTEM, MODEL# B PLUS WIRE 58L (K070485)Cardiva Medical, Inc.2007-03-22
BOOMERANG CLOSUREWIRE VASCULAR CLOSURE SYSTEM (K051817)Cardiva Medical, Inc.2006-12-06
BOOMERANG WIRE (K061075)Cardiva Medical, Inc.2006-09-01
VASOSTASIS VASCULAR CLOSURE SYSTEM (K041486)Cardiva Medical, Inc.2004-10-22